Company Valuation: Clinitech Laboratory Limited

Data adjusted to current consolidation scope
Fiscal Period: March 2025
Market Cap 1 91.84
Change -
Enterprise Value (EV) 1 61.1
Change -
P/E 21.2x
PBR 1.04x
PEG -1.1x
Capitalization / Revenue 1.12x
EV / Revenue 0.74x
EV / EBITDA 7.34x
EV / EBIT 16x
EV / FCF -
FCF Yield -
Dividend per Share 2 -
Rate of return -
EPS 2 1.896
Distribution rate -
Net sales 1 82.35
EBITDA 1 8.319
EBIT 1 3.821
Net income 1 3.947
Net Debt 1 -30.75
Reference price 2 40.24
Nbr of stocks (in thousands) 2,282
Announcement Date 26/8/25
1INR in Million2INR
Estimates

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 948K
-162.94x13.52x-184.09x-.--% 38.87B
19.53x1.89x10.91x1.03% 23.24B
17.59x1.36x7.73x4.96% 7.55B
318.92x - - - 4.89B
47.89x8.51x30.23x1.09% 2.93B
-32.78x - - -.--% 1.9B
28.64x1.01x8.46x0.88% 1.65B
34.16x1.59x12.66x1.49% 1.8B
-18.98x - - - 1.88B
Average 28.00x 4.65x -19.02x 1.35% 8.47B
Weighted average by Cap. -47.65x 8.01x -88.36x 0.88%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. 544220 Stock
  4. Valuation Clinitech Laboratory Limited